Dyssynergia

2

Review clinical trials related to Dyssynergia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Balloon Inflation in Biofeedback

Chronic constipation, particularly due to dyssynergic defecation, is common and impacts quality of life. Biofeedback therapy (BFT) is the most effective conservative treatment, teaching patients to coordinate abdominal and anal muscles during defecation. In standard practice, the rectal balloon used in high-resolution anorectal manometry (HRAM) and biofeedback is left deflated, though some centres inflate it to simulate a more natural urge to defecate. However, the efficacy of this modification has not been validated. This study aims to determine whether performing BFT with the balloon inflated to a patient's defecatory desire volume enhances physiological coordination and patient understanding compared to the standard deflated approach.

Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hull University Teaching Hospitals NHS TrustUpdated: Jul 15, 2026Locations: 1
Eligibility criteria

dyssynergia, constipation, obstructive defecation

Patients with anorectal inflammation due to conditions such as solitary rectal u... [+5]

Status: Recruiting

Fecobionics in Biofeedback Therapy in Dyssynergia Patients

Constipation affects 12-19% of Americans. Pelvic floor dyssynergia is considered to play an important role in constipation but the underlying mechanisms are not well understood in individual patients. The investigators have developed a novel device named Fecobionics that provide detailed mapping of physiological parameters during defecation. The aim of the study is to use Fecobionics to assess anorectal function in dyssynergia patients and monitor and predict the outcome of the biofeedback therapy.

Participants needed: 24
Trial details
Age: 21-75Biological sex: AllType: InterventionalSponsor: The California Medical Innovations Institute, Inc.Updated: Oct 21, 2025Locations: 2
Eligibility criteria

Subject must provide written informed consent. [+2]

Female who is pregnant or lactating. [+6]